...
首页> 外文期刊>Transplantation Proceedings >First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis.
【24h】

First-line liver resection and salvage liver transplantation are increasing therapeutic strategies for patients with hepatocellular carcinoma and child a cirrhosis.

机译:一线肝切除和抢救性肝移植正在增加肝癌和小儿肝硬化患者的治疗策略。

获取原文
获取原文并翻译 | 示例
           

摘要

AIM: The present study focused on nine patients with hepatocellular carcinoma (HCC) associated with Child A liver cirrhosis undergoing first-line liver resection and salvage liver transplantation (SLT) for liver tumor recurrence. PATIENTS AND METHODS: Forty-six patients with HCC underwent liver transplantation (OLT); 37 (80.5%) were primary liver transplantations (PLTs) and 9 (19.5%) were SLTs. All patients who underwent SLT received minor transabdominal liver resections. RESULTS: The posttransplant 1-, 3-, and 5-year overall survival rates for SLT (88.9%, 88.9%, and 88.9%) were similar to those for PLT (78%, 62.7%, and 62.7%). Four (10.8%) patients in the PLT group had HCC recurrence, while there was zero recurrence in the SLT group. The 1-, 3-, 5-year disease-free survival rates for PLT (89%, 74%, and 74%) were similar to those for SLT (100%, 100%, and 100%). The 1-, 3-, 5-year disease-free survival rates after PLT were 89%, 74%, and 74%, and after SLT were 100%, 100%, and 100%, respectively. The operative mortality, intraperioperative bleeding, operative time, intensive care unit stay, in-hospital stay, and overall incidence of postoperative complications were similar in the two groups. CONCLUSIONS: In our experience, SLT for HCC is a feasible procedure with similar results in terms of overall survival, disease-free survival, and postoperative complications to those reported for patients who underwent PLT at our institute. An important role exists for SLT as shown by the fact that such a strategy has been used in the 20% of the patients undergoing OLT for HCC.
机译:目的:本研究的重点是九例伴有Child A肝硬化的肝细胞癌(HCC)患者,他们接受一线肝切除和抢救性肝移植(SLT)以治疗肝肿瘤复发。患者和方法:46例HCC患者接受了肝移植(OLT); 37例(80.5%)为原发性肝移植(PLT),而9例(19.5%)为SLT。所有接受SLT的患者均接受了较小的经腹肝切除术。结果:SLT的移植后1、3和5年总生存率(88.9%,88.9%和88.9%)与PLT相似(分别为78%,62.7%和62.7%)。 PLT组中有4例(10.8%)肝癌复发,而SLT组中零复发。 PLT的1年,3年,5年无病生存率(89%,74%和74%)与SLT相似(100%,100%和100%)。 PLT后的1年,3年,5年无病生存率分别为89%,74%和74%,SLT后为100%,100%和100%。两组的手术死亡率,围手术期出血,手术时间,重症监护病房住院时间,住院时间以及术后并发症的总发生率相似。结论:根据我们的经验,用于肝癌的SLT是一种可行的方法,其总体生存率,无病生存期和术后并发症与我们研究所接受PLT的患者报告的结果相似。事实证明,这种策略已在接受OLT进行HCC的20%的患者中使用,这一事实对SLT发挥了重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号